Hannah Brendan 4
4 · Quince Therapeutics, Inc. · Filed Jun 23, 2025
Insider Transaction Report
Form 4
Hannah Brendan
CBO, COO & CCO
Transactions
- Award
Common Shares
2025-06-18$1.20/sh+37,736$45,283→ 334,276 total - Award
Warrants
2025-06-18$0.13/sh+37,736$4,717→ 37,736 totalExercise: $1.20From: 2025-06-18Exp: 2030-06-18→ Common Shares (37,736 underlying)